Bringing pharmaceutical products to market in China has become much easier for foreign companies. The Chinese FDA (CFDA), now renamed as CNDA, recently made a series of significant changes to the marketing authorisation regulations by issuing a large number of guidelines and opinions (in Chinese).
Speaker: Yingying Liu | View Anytime | Duration: 90 Minutes | Price: ยค190.00 | View Details